Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 1.10B | 1.07B | 1.14B | 999.50M | 1.08B | 976.80M |
Gross Profit | 515.80M | 495.60M | 584.50M | 459.20M | 521.00M | 524.80M |
EBITDA | 238.50M | 256.10M | 238.80M | 285.50M | 235.80M | 175.50M |
Net Income | 36.90M | 33.90M | -63.70M | 25.70M | 18.10M | -40.20M |
Balance Sheet | ||||||
Total Assets | 16.53B | 16.44B | 12.51B | 12.40B | 12.15B | 10.65B |
Cash, Cash Equivalents and Short-Term Investments | 194.30M | 184.80M | 213.10M | 274.20M | 263.45M | 357.26M |
Total Debt | 15.32B | 14.74B | 10.93B | 10.46B | 10.47B | 9.29B |
Total Liabilities | 16.00B | 15.94B | 12.11B | 11.94B | 11.67B | 10.24B |
Stockholders Equity | 531.80M | 492.90M | 401.80M | 456.70M | 476.70M | 415.37M |
Cash Flow | ||||||
Free Cash Flow | -1.27B | -807.00M | -111.80M | -31.70M | -1.30B | -16.30M |
Operating Cash Flow | -945.70M | -573.80M | 10.40M | 173.20M | -468.40M | 261.00M |
Investing Cash Flow | 1.16B | 401.30M | -100.30M | -120.80M | -1.01B | -527.90M |
Financing Cash Flow | -206.50M | 182.90M | 70.80M | -13.40M | 1.38B | 131.80M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
68 Neutral | $17.84B | 12.03 | 10.32% | 3.73% | 9.70% | 0.76% | |
68 Neutral | $733.41M | 8.73 | 15.02% | ― | 35.12% | 25.28% | |
64 Neutral | $341.38M | 10.75 | 7.55% | ― | -2.84% | 2420.57% | |
64 Neutral | $225.14M | 9.90 | 6.65% | ― | 5.49% | 4.30% | |
61 Neutral | $2.91B | 26.72 | 6.26% | 3.06% | 11.18% | 24.94% | |
58 Neutral | $1.24B | 51.21 | 2.12% | 2.49% | 34.62% | -7.94% | |
57 Neutral | $671.78M | ― | -23.67% | ― | 6.60% | 44.77% |
On May 21, 2025, Onity Group held its Annual Meeting of Shareholders where three key proposals were voted on. Shareholders elected directors for one-year terms, ratified Deloitte & Touche LLP as the independent registered public accounting firm for 2025, and approved the executive compensation on a non-binding advisory basis.